| Cindy Martinez, MD | |
|
555 N Duke St, Lancaster, PA 17602-2250 | |
| (717) 544-4940 | |
| Not Available |
| Full Name | Cindy Martinez |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 9 Years |
| Location | 555 N Duke St, Lancaster, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841679537 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD463775 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lancaster General Hospital | Lancaster, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lancaster General Medical Group | 0941103683 | 463 |
News Archive
NexMed, Inc., a specialty CRO with a pipeline of products based on the NexACT® technology, today announced results from a pre-clinical study showing that calcipotriene 0.005% and betamethasone dipropionate 0.064%, when formulated with NexACT®, results in a topical treatment which shows bioequivalecy in efficacy to Talconex®, one of the leading topical treatments marketed for patients with mild to moderate psoriasis.
EpiCept Corporation announced today that it has entered into a definitive agreement with an institutional investor for the purchase of approximately 7.1 million shares of its common stock at $0.65 per share, and five and one half year warrants to purchase up to approximately 5.3 million shares of common stock at an exercise price of $0.72 per share that are not exercisable for six months following the closing date of the offering.
Scientists on the Florida campus of The Scripps Research Institute have developed a new tool for studying the molecular details of protein structure.
The health implications of physical inactivity are truly a global issue with physical inactivity responsible for up to 8% of non-communicable diseases and deaths across the world, finds research published online in British Journal of Sports Medicine.
› Verified 7 days ago
| Entity Name | Lancaster General Health - Columbia Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700972338 PECOS PAC ID: 1254241359 Enrollment ID: O20040128000813 |
News Archive
NexMed, Inc., a specialty CRO with a pipeline of products based on the NexACT® technology, today announced results from a pre-clinical study showing that calcipotriene 0.005% and betamethasone dipropionate 0.064%, when formulated with NexACT®, results in a topical treatment which shows bioequivalecy in efficacy to Talconex®, one of the leading topical treatments marketed for patients with mild to moderate psoriasis.
EpiCept Corporation announced today that it has entered into a definitive agreement with an institutional investor for the purchase of approximately 7.1 million shares of its common stock at $0.65 per share, and five and one half year warrants to purchase up to approximately 5.3 million shares of common stock at an exercise price of $0.72 per share that are not exercisable for six months following the closing date of the offering.
Scientists on the Florida campus of The Scripps Research Institute have developed a new tool for studying the molecular details of protein structure.
The health implications of physical inactivity are truly a global issue with physical inactivity responsible for up to 8% of non-communicable diseases and deaths across the world, finds research published online in British Journal of Sports Medicine.
› Verified 7 days ago
| Entity Name | Lancaster General Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952392383 PECOS PAC ID: 0941103683 Enrollment ID: O20040309000916 |
News Archive
NexMed, Inc., a specialty CRO with a pipeline of products based on the NexACT® technology, today announced results from a pre-clinical study showing that calcipotriene 0.005% and betamethasone dipropionate 0.064%, when formulated with NexACT®, results in a topical treatment which shows bioequivalecy in efficacy to Talconex®, one of the leading topical treatments marketed for patients with mild to moderate psoriasis.
EpiCept Corporation announced today that it has entered into a definitive agreement with an institutional investor for the purchase of approximately 7.1 million shares of its common stock at $0.65 per share, and five and one half year warrants to purchase up to approximately 5.3 million shares of common stock at an exercise price of $0.72 per share that are not exercisable for six months following the closing date of the offering.
Scientists on the Florida campus of The Scripps Research Institute have developed a new tool for studying the molecular details of protein structure.
The health implications of physical inactivity are truly a global issue with physical inactivity responsible for up to 8% of non-communicable diseases and deaths across the world, finds research published online in British Journal of Sports Medicine.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Cindy Martinez, MD 555 N Duke St, Lancaster, PA 17602-2250 Ph: () - | Cindy Martinez, MD 555 N Duke St, Lancaster, PA 17602-2250 Ph: (717) 544-4940 |
News Archive
NexMed, Inc., a specialty CRO with a pipeline of products based on the NexACT® technology, today announced results from a pre-clinical study showing that calcipotriene 0.005% and betamethasone dipropionate 0.064%, when formulated with NexACT®, results in a topical treatment which shows bioequivalecy in efficacy to Talconex®, one of the leading topical treatments marketed for patients with mild to moderate psoriasis.
EpiCept Corporation announced today that it has entered into a definitive agreement with an institutional investor for the purchase of approximately 7.1 million shares of its common stock at $0.65 per share, and five and one half year warrants to purchase up to approximately 5.3 million shares of common stock at an exercise price of $0.72 per share that are not exercisable for six months following the closing date of the offering.
Scientists on the Florida campus of The Scripps Research Institute have developed a new tool for studying the molecular details of protein structure.
The health implications of physical inactivity are truly a global issue with physical inactivity responsible for up to 8% of non-communicable diseases and deaths across the world, finds research published online in British Journal of Sports Medicine.
› Verified 7 days ago
Jon David Lepley, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 540 Duke St, Lancaster, PA 17602 Phone: 717-544-4950 | |
Dr. Lindsi Anne Dearment, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1871 Santa Barbara Dr Ste 1, Lancaster, PA 17601 Phone: 717-560-1970 Fax: 717-560-2278 | |
Emily Kirchner, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 555 N Duke St, Lancaster, PA 17602 Phone: 717-544-4940 | |
Dr. John T Cotter Jr., MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2207 Oregon Pike Ste 202, Lancaster, PA 17601 Phone: 717-560-6470 Fax: 717-560-6472 | |
Dr. Spencer D Phillips, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2113 Manor Ridge Dr, Lancaster, PA 17603 Phone: 717-517-7841 Fax: 717-517-7853 | |
Danielle J Miller, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3045 Marietta Ave, Lancaster, PA 17601 Phone: 717-898-2900 | |
Dr. Christine Janouschek, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 210 S Prince St, Lancaster, PA 17603 Phone: 717-393-7709 |